Abstract 1136: Detection and characterization of circulating tumor cells in localized and metastatic prostate cancer patients using CTC-Chip microfluidic technology
Sunitha Nagrath(University of Michigan), Mehmet Toner(Center for Cancer Research), Daniel A. Haber(Howard Hughes Medical Institute), Min Yu(Howard Hughes Medical Institute), Richard J. Lee(La Roche College), Matthew Ryan Smith(Massachusetts General Hospital), Shyamala Maheswaran(Massachusetts General Hospital), Shannon L. Stott(Shriners Hospitals for Children - Erie), Lecia V. Sequist(Harvard University), Ronald G. Tompkins(Nashville Oncology Associates), Lindsey Ulkus(Harvard University), John Iafrate(Harvard University)
Cited by 34
Related Papers
Improved Survival with Vemurafenib in Melanoma with BRAF V600E Mutation
|New England Journal of Medicine|2011|7.7k
Isolation of rare circulating tumour cells in cancer patients by microchip technology
|Nature|2007|3.5k
Inhibition of Mutated, Activated BRAF in Metastatic Melanoma
|New England Journal of Medicine|2010|3.5k
Phase III Study of Afatinib or Cisplatin Plus Pemetrexed in Patients With Metastatic Lung Adenocarcinoma With <i>EGFR</i> Mutations
|Journal of Clinical Oncology|2013|3.2k
Genomic responses in mouse models poorly mimic human inflammatory diseases
|Proceedings of the National Academy of Sciences|2013|3k